Kitov Pharma (KTOV)

0.78 -0.08 (9.30%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form SC 13G Kitov Pharma Ltd. Filed by: ARMISTICE CAPITAL, LLC July 6, 2020 5:00 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Jul 02 July 2, 2020 4:19 PM - SEC Filing Kitov Pharma (KTOV) Issues CEO Shareholder Letter Providing Business Update July 2, 2020 8:47 AM - StreetInsider Form 6-K Kitov Pharma Ltd. For: Jul 02 July 2, 2020 8:36 AM - SEC Filing Kitov Pharma Issues CEO Shareholder Letter Providing Business Update July 2, 2020 8:34 AM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: Jul 01 July 1, 2020 4:50 PM - SEC Filing Form 6-K/A Kitov Pharma Ltd. For: Jun 29 June 30, 2020 6:25 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Jun 25 June 25, 2020 4:31 PM - SEC Filing Kitov Closes $35.0 Million Registered Direct Offering June 25, 2020 4:30 PM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: Jun 25 June 25, 2020 11:17 AM - SEC Filing Form 424B5 Kitov Pharma Ltd. June 25, 2020 11:14 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Jun 23 June 23, 2020 4:05 PM - SEC Filing Kitov Pharma (KTOV) Announces 38.89M ADS Registered Direct Offering at $0.90/ADS June 23, 2020 1:21 PM - StreetInsider Kitov Announces $35.0 Million Registered Direct Offering June 23, 2020 1:20 PM - Globe NewsWire Kitov Pharma (KTOV) Surges on Portnoy Recommendation June 23, 2020 10:49 AM - StreetInsider Form 6-K Kitov Pharma Ltd. For: May 22 May 22, 2020 7:02 AM - SEC Filing Kitov Pharma (KTOV) Announces U.S. FDA Acceptance of Investigational NDA to Conduct Phase 1/2 Clinical Trial of NT219 in Multiple Types of Advanced Cancer Patients May 22, 2020 7:01 AM - StreetInsider Kitov Announces U.S. FDA Acceptance of Investigational New Drug Application to Conduct Phase 1/2 Clinical Trial of NT219 in Multiple Types of Advanced Cancer Patients May 22, 2020 7:00 AM - Globe NewsWire Form EFFECT Kitov Pharma Ltd. May 21, 2020 6:02 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 20 May 20, 2020 8:16 AM - SEC Filing Kitov Announces U.S. Commercial Launch of Consensiā„¢ May 20, 2020 7:30 AM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: May 19 May 19, 2020 4:31 PM - SEC Filing Kitov to Present Preclinical Data on NT219 at American Association of Cancer Research Virtual Annual Meeting II May 19, 2020 8:05 AM - Globe NewsWire Form S-8 Kitov Pharma Ltd. May 18, 2020 5:25 PM - SEC Filing Form D Kitov Pharma Ltd. May 15, 2020 4:49 PM - SEC Filing Form SC 13G Kitov Pharma Ltd. Filed by: ARMISTICE CAPITAL, LLC May 15, 2020 4:46 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 14 May 14, 2020 7:13 AM - SEC Filing Kitov to Present Phase 1 Data on CM-24 in Patients with Advanced Cancer at American Society of Clinical Oncology 2020 Virtual Scientific Program May 14, 2020 7:10 AM - Globe NewsWire Form F-3 Kitov Pharma Ltd. May 13, 2020 4:33 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 08 May 8, 2020 4:20 PM - SEC Filing Kitov Closes $10 Million Registered Direct Offering May 8, 2020 4:00 PM - Globe NewsWire Form 6-K Kitov Pharma Ltd. For: May 08 May 8, 2020 10:41 AM - SEC Filing Form 424B5 Kitov Pharma Ltd. May 8, 2020 10:40 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 06 May 6, 2020 4:30 PM - SEC Filing Form SC 13G Kitov Pharma Ltd. Filed by: SABBY MANAGEMENT, LLC May 6, 2020 11:56 AM - SEC Filing Kitov Pharma (KTOV) Announces $10 million Registered Direct Offering of ADSs May 6, 2020 8:04 AM - StreetInsider Kitov Announces $10 million Registered Direct Offering May 6, 2020 8:00 AM - Globe NewsWire Form D Kitov Pharma Ltd. May 4, 2020 4:03 PM - SEC Filing Form 6-K Kitov Pharma Ltd. For: May 04 May 4, 2020 8:57 AM - SEC Filing Form 6-K Kitov Pharma Ltd. For: Apr 20 April 20, 2020 9:29 AM - SEC Filing Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warrants April 20, 2020 8:05 AM - Globe NewsWire Full Article List